Kyron.bio
Faubourg Saint-jacques
About Kyron.bio
Kyron.bio uses the power of glycan alterations to enable improved protein therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.8M
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: kyron.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/kyron-bio-106145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.